Laboratory Corporation of America has named Deborah Keller as the CEO of Covance Drug Development. She takes over for Joseph Herring who will retire on July 31 after more than a decade as CEO.
Keller joined Covance in 1987 and has held senior leadership roles in global operations, quality assurance, and marketing. Most recently she served as executive vice president of Covance and group president of R&D Laboratories where she led more than 6,000 employees at 18 facilities across the globe.
Qiagen said that Brad Crutchfield has joined the company as senior vice president, head of the life sciences business area, and a member of the executive committee. He previously served as vice president and general manager EMEA at Illumina. Prior to that, he held positions of increasing responsbility at Bio-Rad Laboratories, most recently as executive vice president and president of the life science group.
Matthew Fischer has joined GenoSpace as vice president of sales and marketing. He joins the cloud-based software solutions company from Intuitive Surgical and has more than 15 years of experience in sales and marketing. Prior to Intuitive he was at Robert Half International and at Boston Scientific.
Kailos Genetics has hired Cheri Walker as chief financial officer and senior vice president of corporate development.
Walker brings with her 18 years of experience in the life science and diagnostic market. She has worked previously as an equity analyst for Deutsche Bank; in senior level corporate development and operating roles at Invitrogen, Qiagen, and Charles River Labs; and served on the board of directors of Diatherix Laboratories. Walker earned her PhD in human and molecular genetics from Baylor College of Medicine.
For more recent items on executive appointments and promotions in the omics and molecular diagnostics industries, please see the People in the News page on our website.